1. Home
  2. ADPT vs LBRT Comparison

ADPT vs LBRT Comparison

Compare ADPT & LBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • LBRT
  • Stock Information
  • Founded
  • ADPT 2009
  • LBRT 2011
  • Country
  • ADPT United States
  • LBRT United States
  • Employees
  • ADPT N/A
  • LBRT N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • LBRT Oilfield Services/Equipment
  • Sector
  • ADPT Health Care
  • LBRT Energy
  • Exchange
  • ADPT Nasdaq
  • LBRT Nasdaq
  • Market Cap
  • ADPT 1.8B
  • LBRT 1.8B
  • IPO Year
  • ADPT 2019
  • LBRT 2018
  • Fundamental
  • Price
  • ADPT $12.85
  • LBRT $10.48
  • Analyst Decision
  • ADPT Strong Buy
  • LBRT Hold
  • Analyst Count
  • ADPT 8
  • LBRT 9
  • Target Price
  • ADPT $12.38
  • LBRT $15.50
  • AVG Volume (30 Days)
  • ADPT 1.8M
  • LBRT 2.8M
  • Earning Date
  • ADPT 08-05-2025
  • LBRT 10-15-2025
  • Dividend Yield
  • ADPT N/A
  • LBRT 3.06%
  • EPS Growth
  • ADPT N/A
  • LBRT N/A
  • EPS
  • ADPT N/A
  • LBRT 1.30
  • Revenue
  • ADPT $205,216,000.00
  • LBRT $4,102,134,000.00
  • Revenue This Year
  • ADPT $32.76
  • LBRT N/A
  • Revenue Next Year
  • ADPT $15.81
  • LBRT $0.08
  • P/E Ratio
  • ADPT N/A
  • LBRT $8.05
  • Revenue Growth
  • ADPT 21.60
  • LBRT N/A
  • 52 Week Low
  • ADPT $3.98
  • LBRT $9.50
  • 52 Week High
  • ADPT $13.52
  • LBRT $23.58
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.00
  • LBRT 39.20
  • Support Level
  • ADPT $12.62
  • LBRT $10.25
  • Resistance Level
  • ADPT $13.25
  • LBRT $11.42
  • Average True Range (ATR)
  • ADPT 0.55
  • LBRT 0.41
  • MACD
  • ADPT -0.05
  • LBRT -0.02
  • Stochastic Oscillator
  • ADPT 58.13
  • LBRT 18.29

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About LBRT Liberty Energy Inc.

Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.

Share on Social Networks: